One study found that increased expression of autophagy-related proteins ATG5 and ATG16L2 promotes the development of SLE, suggesting that targeting and reducing the expression of ATG5 and ATG16L2 can treat SLE (107). Here, ATG5 is linked to systemic lupus erythematosus.